🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy blood pressure normalization journey — July 2024 Page 2

My blood pressure normalization journey — July 2024

JessicaH_TX Wed, May 21, 2025 at 1:11 PM 25 replies 1,700 viewsPage 2 of 5
fiona_VT
Member
178
890
Dec 2024
Vermont
May 21, 2025 at 4:01 PM#6

It was noticeable within the first 6-8 weeks, honestly. By month 2 I was seeing readings in the low 120s/high 70s consistently, which was lower than I'd been in years even on medications. My PCP said the early improvement likely reflects both the natriuretic effect and reduced caloric intake affecting fluid balance.

But the real BP improvements correlated with substantial weight loss. The biggest drops came between months 2-6 when I was losing the most weight. After that it stabilized.

49 13mark_tokyo, hans_munich, jason_sac26 and 46 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
May 21, 2025 at 4:18 PM#7

For context, here's what the aggregate trial data shows for BP reduction with semaglutide 2.4 mg:

TrialPopulationSBP Reduction (vs. placebo)Weight Loss
STEP 1Obesity, no T2DM-5.1 mmHg-12.4%
STEP 2Obesity + T2DM-3.6 mmHg-9.6%
STEP 3Obesity + IBT-5.6 mmHg-16.0%
SELECTObesity + CVD-3.4 mmHg-9.4%

These are mean population-level effects. Individual responses can be much more dramatic, especially in patients with higher baseline BP. The OP's result is exceptional but not unheard of in clinical practice.

49 18Admin, Dr.Martinez, mike_mod and 46 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 21, 2025 at 4:35 PM#8

Great discussion. I want to flag something important for members reading this: never stop or reduce blood pressure medications on your own. The OP did this under close medical supervision with a planned de-escalation protocol. Abruptly stopping BP meds can cause rebound hypertension, which carries real risk.

If you're experiencing lower BP readings on GLP-1 therapy, bring those readings to your physician and let them guide the medication adjustment. Safety first.

Last edited: May 21, 2025 at 6:35 PM
18 8DoseLogDan, SleepFixSam, PurityPaulOR and 15 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
May 21, 2025 at 4:52 PM#9

Echoing the mod's comment. I'll add that the patients who benefit the most from BP medication reduction on GLP-1 therapy tend to be those whose hypertension was primarily driven by obesity, insulin resistance, and volume overload — rather than primary/essential hypertension with strong genetic components.

If your hypertension was diagnosed at a normal BMI with a strong family history, don't expect the same degree of de-escalation. The etiology matters enormously.

For patients with obesity-related hypertension, however, GLP-1 RA therapy combined with weight loss can genuinely be transformative. I've had patients come off 3-4 medications. It's remarkable and, in my 20 years of practice, unprecedented for any single intervention to achieve this so consistently.

45 3tommy_boulder, hyun_seoul, jim_asheville and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register